Skip to content

Electrical Stimulation and the potential therapeutic approach in different populations

Transcranial Direct Current Stimulation and the potential therapeutic approach in different populations

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-9hyfc4v
Enrollment
Unknown
Registered
2022-11-22
Start date
2023-06-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic Neuropathie

Interventions

This is a double-blind, randomized controlled trial with two arms 2that consists of uses a transcranial direct current stimulation (tDCS) through a pair of 35cm2 sponge electrodes embedded with saline
E02.331.750

Sponsors

Faculdade de Ciências da Saúde do Trairí
Lead Sponsor
Hospital Universitário Onofre Lopes
Collaborator

Eligibility

Age
30 Years to 69 Years

Inclusion criteria

Inclusion criteria: Participants were selected from a specialized outpatient service and regarded as suitable to participate in this study if they fulfilled the following criteria: clinical diagnoses of diabetic polyneuropathy; aged from 30 to 69 years; not lactating; no history of brain surgery, tumor, or intracranial metal implantation

Exclusion criteria

Exclusion criteria: Participants with any uncontrolled clinical disease, such as thyroid disease, cardiovascular, pulmonary, haematological or renal disease; alcohol or other substance abuse; pregnancy; lactation; neuropsychiatric disorders; history of epilepsy and metallic implants in the head were excluded; patients with significant cognitive dysfunction

Design outcomes

Primary

MeasureTime frame
Pain improvement in active M1 group, evaluated through the visual analogue scale for pain with an increase of 30%

Secondary

MeasureTime frame
Quality of life improvement in active M1 group, verified through the SF-36 questionnaire, from the verification of a 30% increase;Functional capacity improvement in active M1 group, verified through the six minutes walking test, by increasing the distance that participant walked

Countries

Brazil

Contacts

Public ContactRodrigo Freitas

Universidade Federal do Rio Grande do Norte

rodrigopegado@gmail.com+55(84)33422385

Outcome results

None listed

Source: REBEC (via WHO ICTRP)